Susquehanna Fundamental Investments, LLC Compugen LTD Transaction History

Susquehanna Fundamental Investments, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.66 - $2.32 $64,023 - $225,053	-97,006 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.76 - $4.64 $58,012 - $97,528	-21,019 Reduced 17.81%	97,006 $312,000
Q4 2021 Feb 14, 2022	BUY	$4.09 - $7.16 $72,213 - $126,416	17,656 Added 17.59%	118,025 $508,000
Q3 2021 Nov 15, 2021	BUY	$5.8 - $8.02 $226,600 - $313,333	39,069 Added 63.73%	100,369 $599,000
Q2 2021 Aug 11, 2021	BUY	$6.87 - $9.16 $421,131 - $561,508	61,300 New	61,300 $508,000
Q1 2021 May 17, 2021	SELL	$7.67 - $13.77 $76,715 - $137,727	-10,002 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$12.07 - $17.95 $1.08 Million - $1.6 Million	-89,198 Reduced 89.92%	10,002 $121,000
Q3 2020 Nov 16, 2020	BUY	$14.16 - $19.45 $4,248 - $5,835	300 Added 0.3%	99,200 $1.61 Million
Q2 2020 Aug 14, 2020	BUY	$6.97 - $17.12 $689,333 - $1.69 Million	98,900 New	98,900 $1.49 Million

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $129M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.